FANS输尿管鞘辅助输尿管软镜与微通道经皮肾镜治疗2-3cm上尿路结石的随机对照试验及2-2.5cm亚组分析
这项随机对照试验纳入326例2-3cm上尿路结石患者,1:1随机接受FANS辅助输尿管软镜或微通道经皮肾镜治疗。总体队列中两组即刻和1个月清石率相当,FANS组手术时间更长但血红蛋白下降更少、住院时间更短;在2-2.5cm亚组中FANS清石率非劣效且手术时间未显著延长。
要点
- 2-3cm上尿路结石中,FANS辅助输尿管软镜与微通道经皮肾镜清石率相当。
- FANS组出血更少、住院更短,但总体手术时间更长。
- 2-2.5cm亚组中FANS综合获益优于微通道经皮肾镜。
核心结论
- 对于2-3cm上尿路结石,FANS辅助输尿管软镜清石率与微通道经皮肾镜相当,并具有失血少和住院时间短的优点。
- 在2-2.5cm亚组中,FANS较微通道经皮肾镜展现出综合优势,可能成为优先选择。
研究设计与样本
- 预设对结石≥2且<2.5cm进行亚组分析,主要结局为即刻和1个月清石率。
主要发现
- 总体2-3cm队列中,FANS组即刻和1个月清石率与微通道经皮肾镜组相当。
- FANS组手术时间更长,但血红蛋白下降显著更少、住院时间更短,感染相关并发症无显著差异。
- 在≥2且<2.5cm亚组中,FANS组两个时间点清石率非劣效,且手术时间未显著长于微通道经皮肾镜组。
关键数值与推荐
- 主要结局为即刻和1个月清石率(SFR)。
- 次要结局包括手术时间、血红蛋白下降、住院时间和并发症发生率。
临床怎么用
- 对于2-3cm上尿路结石,FANS辅助输尿管软镜可作为微通道经皮肾镜的有效替代方案。
- 对于2-2.5cm结石,可优先考虑FANS辅助输尿管软镜。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the safety and efficacy of flexible ureteroscopy (f-URS) with a flexible and navigable suction ureteral access sheath (FANS) compared with mini-percutaneous nephrolithotomy (mPCNL) in the treatment of 2-3 cm upper urinary tract stones (UUTS), with a prespecified subgroup analysis for stones ≥2 to <2.5 cm. METHODS: This randomized controlled trial enrolled 326 patients with 2-3 cm UUTS between June 2023 and December 2025. Patients were randomly assigned in a 1:1 ratio to undergo either f-URS with FANS or mPCNL. A prespecified subgroup analysis was conducted for stones measuring ≥2 to <2.5 cm. The primary outcomes were the immediate and 1-month stone-free rate (SFR). Secondary outcomes included the operative duration, decrease in haemoglobin, hospital stay, and complication rate. RESULTS: The baseline characteristics were comparable between the two groups. In the overall 2-3 cm cohort, the FANS group achieved immediate and 1-month SFRs comparable to those of the mPCNL group. Although the operative time was longer in the FANS group, it was associated with significantly less haemoglobin loss and a shorter hospital stay, with no significant difference in infection-related complications. Notably, in the subgroup of stones ≥2 to <2.5 cm, the FANS group demonstrated a non-inferior SFR at both time points, and the operative time was not significantly longer than that of the mPCNL group. CONCLUSION: For 2-3 cm UUTS, f-URS with FANS offers a SFR comparable to that of mPCNL, along with the advantages of reduced blood loss and shorter hospitalization. In the ≥2 to <2.5 cm subgroup, FANS shows comprehensive benefits over mPCNL. These findings support FANS as an effective alternative to mPCNL for 2-3 cm stones and a potentially preferred option for stones measuring 2-2.5 cm.
引用
- Wang R, Qi X, Li C, et al. F-URS with FANS versus mPCNL for 2-3 cm UUTS: a RCT with a subgroup analysis of 2-2.5 cm stones. BJU Int. 2026. PMID: 42381433. doi:10.1111/bju.70367
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。